ArriVent BioPharma (AVBP) PT Raised to $38 at Goldman Sachs
Tweet
Share
E-mailGet Alerts AVBP Hot Sheet
Price: $29.17 -3.09%
Rating Summary:
13 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Rating Summary:
13 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 18
Join SI Premium – FREE
Goldman Sachs analyst Corinne Johnson raised the price target on ArriVent BioPharma (NASDAQ: AVBP) to $38.00 (from $28.00) while maintaining a Buy rating.
You May Also Be Interested In
- Costco Wholesale (COST) PT Raised to $1,040 at DA Davidson Following Q4 Earnings
- Costco Wholesale (COST) PT Lowered to $1,015 at JPMorgan
- Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
